Cargando…

Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

BACKGROUND AND PURPOSE: Selecting an ideal antithrombotic therapy for elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) can be challenging since they have a higher thromboembolic and bleeding risk than younger patients. The current study aimed to asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sambola, Antonia, Mutuberría, Maria, García del Blanco, Bruno, Alonso, Albert, Barrabés, José A., Bueno, Héctor, Alfonso, Fernando, Cequier, Angel, Zueco, Javier, Rodríguez-Leor, Oriol, Tornos, Pilar, García-Dorado, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726489/ https://www.ncbi.nlm.nih.gov/pubmed/26808678 http://dx.doi.org/10.1371/journal.pone.0147245

Ejemplares similares

Editorial: Management of right ventricular failure: pathophysiology, medical treatment and use of ventricular assist devices
por: Soriano-Colomé, Toni, et al.
Publicado: (2023)

MRI Discriminates Thrombus Composition and ST Resolution after Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction
por: Barba, Ignasi, et al.
Publicado: (2011)

Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease
por: Sambola, Antonia, et al.
Publicado: (2023)

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
por: Kozieł, Monika, et al.
Publicado: (2020)

Rhabdomyolysis complicating percutaneous radiofrequency ablation of persistent atrial fibrillation
por: Churchhouse, Antonia Maria Diane, et al.
Publicado: (2015)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Triple threat: adiposity, aging, atrial fibrillation
por: Anumonwo, Justus M., et al.
Publicado: (2017)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation, Second Thoughts?
por: Wagdi, Philipp, et al.
Publicado: (2012)

Simultaneous Sensing and Actuating Capabilities of a Triple-Layer Biomimetic Muscle for Soft Robotics
por: García-Córdova, Francisco, et al.
Publicado: (2023)

Atrioesophageal fistula from percutaneous ablation for atrial fibrillation
por: Felmly, Lloyd M., et al.
Publicado: (2020)

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
por: Berteotti, M., et al.
Publicado: (2023)

Evidence-Based Percutaneous Closure of the Left Atrial Appendage in Patients with Atrial Fibrillation
por: Leal, Sílvio, et al.
Publicado: (2012)

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
por: De Backer, O, et al.
Publicado: (2014)

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention
por: Mirra, M, et al.
Publicado: (2014)

Balancing between bleeding and thromboembolism after percutaneous coronary intervention in patients with atrial fibrillation. Could triple anticoagulant therapy be a solution?
por: Dąbrowska, Magdalena, et al.
Publicado: (2013)

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
por: Goette, Andreas, et al.
Publicado: (2020)

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: A meta-analysis
por: Moustafa, Abdelmoniem, et al.
Publicado: (2020)

Atrial fibrillation in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2019)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
por: Yu, Yunan, et al.
Publicado: (2022)

Impact of Percutaneous Mitral Valve Repair on Left Atrial Strain and Atrial Fibrillation Progression
por: Romano, Letizia Rosa, et al.
Publicado: (2023)

Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion
por: Mikhaylov, Evgeny N, et al.
Publicado: (2017)

Predictors of Acute Failure Ablation of Intra‐atrial Re‐entrant Tachycardia in Patients With Congenital Heart Disease: Cardiac Disease, Atypical Flutter, and Previous Atrial Fibrillation
por: Roca‐Luque, Ivo, et al.
Publicado: (2018)

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
por: Hamaguchi, Toka, et al.
Publicado: (2021)

Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation
por: Sánchez, Carlos, et al.
Publicado: (2014)

Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
por: Jin, Lu-Shen, et al.
Publicado: (2022)

Percutaneous elimination of the left atrial appendage in quest for effective and safe prevention of stroke in patients with atrial fibrillation
por: Pracoń, Radosław, et al.
Publicado: (2014)

Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
por: Schellinger, Peter D., et al.
Publicado: (2018)

Percutaneous left atrial appendage closure in a patient with haemophilia and atrial fibrillation: a case report
por: Güray, Ümit, et al.
Publicado: (2019)

Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding
por: Cimmino, Giovanni, et al.
Publicado: (2021)

Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Isogai, Toshiaki, et al.
Publicado: (2021)

Percutaneous Retrieval of Left Atrial Appendage Closure Devices in Patients With Atrial Fibrillation: A Case Report
por: Wang, Saihua, et al.
Publicado: (2022)

Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation
por: Zhang, Xiaochun, et al.
Publicado: (2022)

Poor outcome following percutaneous balloon mitral valvotomy in patients with atrial fibrillation
por: Aslanabadi, Naser, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7660olull4vpe8t89eeg0fhccs